Epidiolex Clinical Review Timeline
Chronicle of the development and US FDA review of GW Pharmaceutical's Epidiolex (cannabidiol) for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients ages 2 and older.
Chronicle of the development and US FDA review of GW Pharmaceutical's Epidiolex (cannabidiol) for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients ages 2 and older.